Clinical Outcomes for Neuroendocrine Tumors of the Duodenum and Ampulla of Vater:A Population-Based Study

Journal of Gastrointestinal Surgery

Volumn 18, Issue 2, 2014, Pages 354-362

  Randle, Reese W ^a   Ahmed, Shuja ^a   Newman, Naeem A ^a   Clark, Clancy J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Ampulla of Vater; Carcinoid; Duodenum; Neuroendocrine tumor; SEER

Indexed keywords

AGED; ARTICLE; BILE DUCT TUMOR; CANCER GRADING; CANCER REGISTRY; CARCINOID; CARCINOMA; COMPARATIVE STUDY; DUODENUM TUMOR; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME; VATER PAPILLA;

AGED; AMPULLA OF VATER; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; COMMON BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TUMOR BURDEN;

EID: 84893236155     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2365-4     Document Type: Article

References (23)

1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 2008 20;26(18): 3063-72.
2. Surveillance, Epidemiology and End Results (SEER). National Cancer Institute, Bethesda, MD. 2013. Available at: http://seer. cancer. gov. Accessed November 15, 2012.
3. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39(6): 707-12.
4. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963 2;1(7275): 238-9.
5. Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW. Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management. Arch Surg 2009;144(6): 527-31.
6. Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 1999 15;85(6): 1241-9.
7. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990;114(7): 700-4.
8. Hatzitheoklitos E, Buchler MW, Friess H, Poch B, Ebert M, Mohr W, et al. Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer 1994 15;73(6): 1580-8.
9. Bornstein-Quevedo L, Gamboa-Dominguez A. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol 2001;32(11): 1252-6.
10. De Palma GD, Masone S, Siciliano S, Maione F, Falleti J, Mansueto G, et al. Endocrine carcinoma of the major papilla: report of two cases and review of the literature. Surg Oncol 2010;19(4): 235-42.
11. Hartel M, Wente MN, Sido B, Friess H, Buchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 2005;20(5): 676-81.
12. Ozsoy M, Ozsoy Y, Canda AE, Nalbant OA, Haskaraca F. The rare malignancy of the hepatobiliary system: ampullary carcinoid tumor. Case Report Med 2011;2011: 173036.
13. Clements WM, Martin SP, Stemmerman G, Lowy AM. Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg 2003;7(6): 773-6.
14. Ricci JL. Carcinoid of the ampulla of Vater. Local resection or pancreaticoduodenectomy. Cancer 1993 1;71(3): 686-90.
15. Gilani N, Ramirez FC. Endoscopic resection of an ampullary carcinoid presenting with upper gastrointestinal bleeding: a case report and review of the literature. World J Gastroenterol 2007 28;13(8): 1268-70.
16. Pyun DK, Moon G, Han J, Kim MH, Lee SS, Seo DW, et al. A carcinoid tumor of the ampulla of Vater treated by endoscopic snare papillectomy. Korean J Intern Med 2004;19(4): 257-60.
17. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007 20;370(9596): 1453-1457.
18. Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, et al. Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg 2001;5(6): 588-93.
19. Fukatsu H, Kawamoto H, Fujii M, Tsutsumi K, Kato H, Hirao K, et al. Periampullary carcinoid tumor. Endoscopy 2007 Feb;39 Suppl 1: E49-E50.
20. Hwang S, Lee SG, Lee YJ, Han DJ, Kim SC, Kwon SH, et al. Radical surgical resection for carcinoid tumors of the ampulla. J Gastrointest Surg 2008;12(4): 713-7.
21. Dumitrascu T, Dima S, Herlea V, Tomulescu V, Ionescu M, Popescu I. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis. Langenbecks Arch Surg 2012;397(6): 933-43.
22. Klimstra DS. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. Semin Oncol 2013;40(1): 23-36.
23. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008;15(2): 415-23.